Elizabeth Cermak
Directeur/Membre du Conseil chez MOLECULIN BIOTECH, INC.
Fortune : - $ au 30/04/2024
Provenance du réseau au premier degré de Elizabeth Cermak
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 10 | |
| Public Company | Pharmaceuticals: Major | 10 | |
| Subsidiary | Pharmaceuticals: Major | 9 | |
| Extinct | Pharmaceuticals: Major | 9 | |
SteadyMed Therapeutics, Inc.
 SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA.
2
| Holding Company | Medical/Nursing Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Elizabeth Cermak via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | President | |
Drypers Corp.
 Drypers Corp. Household/Personal CareConsumer Non-Durables Part of Elite Shine Investments Ltd., Drypers Corp. is a company that manufactures and markets disposable diapers, training pants, and pre-moistened wipes. The company is based in Houston, TX. The company was founded by Walter V. Klemp. Drypers was acquired by Associated Hygienic Products LLC, part of Elite Shine Investments Ltd., from July 01, 2013, on June 04, 2001, for $38.50 million. | Household/Personal Care | Chief Executive Officer Director of Finance/CFO | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member President | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | President Director of Finance/CFO | |
| UNITED THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
| CNS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| The Financial Executives Institute | Corporate Officer/Principal Corporate Officer/Principal | ||
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Unither Therapeutik GmbH
 Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| The Johns Hopkins University | College/University | Graduate Degree Doctorate Degree | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Director/Board Member Founder | |
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| LIQUIDIA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| MIROMATRIX MEDICAL INC. | Biotechnology | Director of Finance/CFO General Counsel | |
Blue Water Acquisition Corp. II
 Blue Water Acquisition Corp. II Financial ConglomeratesFinance Blue Water Acquisition Corp. II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Hernandez and is headquartered in Greenwich, CT. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| SOLITON, INC. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| INFUSYSTEM HOLDINGS, INC. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
Moleculin LLC
 Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Chief Executive Officer President | |
| AUTONOMIX MEDICAL, INC. | Medical Specialties | Chairman Director/Board Member | |
Embolitech LLC
 Embolitech LLC Miscellaneous Commercial ServicesCommercial Services Embolitech LLC provides thrombomatrix technology. The firm’s initial research areas focus on the removal of organized thrombi and emboli. It’s Thrombomatrix technology will redefine treatment of peripheral vascular emboli and thrombi. The company was founded by Gary Ansel and Michael R. Jaff in 2016 and is headquartered in Austin, TX. | Miscellaneous Commercial Services | Chief Executive Officer | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
| PRIVATE RENTED SECTOR S.A. | Biotechnology | Corporate Officer/Principal | |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ortho-mcneil Neurologics, Inc. | President | ||
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman | |
| The GW School of Business | College/University | Undergraduate Degree | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Private Equity Investor | |
| Arizona State University | College/University | Undergraduate Degree | |
| University of Twente | College/University | Doctorate Degree | |
Organon Pharmaceuticals USA, Inc.
 Organon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Organon Pharmaceutical USA, Inc. markets and distributes pharmaceutical products. Its products include contraceptives and anesthetics, as well as treatments for mental health disorders. The company is headquartered in Roseland, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Biotechnology | Director of Finance/CFO | |
| BOTANIX PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director of Finance/CFO | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director of Finance/CFO | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO |
Statistiques
Internationale
| Etats-Unis | 39 |
| Nouvelle-Zélande | 2 |
| Allemagne | 2 |
| Canada | 2 |
| Pologne | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Finance | 5 |
| Consumer Non-Durables | 2 |
Opérationnelle
| Director/Board Member | 166 |
| Corporate Officer/Principal | 68 |
| Independent Dir/Board Member | 48 |
| Chief Executive Officer | 48 |
| Chairman | 43 |
Relations les plus connectées
| Insiders | |
|---|---|
| Seth A. Rudnick | 36 |
| Alf Gunnar Martin Nicklasson | 31 |
| Joseph Hernandez | 20 |
| John Climaco | 18 |
| Alex Zisson | 18 |
| Neal Fowler | 16 |
| Jonathan Foster | 16 |
| Stephen Farr | 16 |
| Donald Huffman | 16 |
| Donald Picker | 16 |
| Keith T. Bank | 16 |
| Ronny Ginor | 14 |
| Kimberly Murphy | 13 |
| Richard Peterson | 13 |
| Mark Prygocki | 12 |
- Bourse
- Insiders
- Elizabeth Cermak
- Connexions Sociétés
